Integrated Diagnostics : AGM 2023 - Summary of Proxy Voting
May 30, 2023 at 05:08 pm
Share
ANNUAL GENERAL MEETING 2023 - SUMMARY OF PROXY VOTING
VOTES FOR
%
VOTES
%
VOTES
TOTAL
% OF
AGAINST
WITHHELD
SHARES
ISSUED
VOTED
SHARE
CAPITAL
VOTED
ORDINARY
RESOLUTIONS
1. To receive and
consider the
Company's Audited
Financial Statements,
together with the
Reports of the
Directors and the
Auditor for the year
ended 31 December
2022.
459,097,791
93.69
30,935,098
6.31
0
490,032,889
81.67
2. To re-elect Lord
Anthony Tudor St John
as a Director.
462,899,048
99.59
1,895,129
0.41
25,238,712
464,794,177
77.47
3. To re-elect Dr. Hend
El-Sherbini as a
Director.
464,039,840
99.84
754,337
0.16
25,238,712
464,794,177
77.47
4. To re-elect Richard
Henry Phillips as a
Director.
464,039,840
99.84
754,337
0.16
25,238,712
464,794,177
77.47
5. To re-elect ~Dan
Johan Wilmar Olsson
as a Director.
444,525,851
95.64
20,268,326
4.36
25,238,712
464,794,177
77.47
6. To re-elect Hussein
Hassan Choucri as a
Director.
464,735,879
99.99
58,298
0.01
25,238,712
464,794,177
77.47
7. To re-elect Yvonne
Stillhart as a Director.
464,735,879
99.99
58,298
0.01
25,238,712
464,794,177
77.47
8. To re-appoint PwC
LLP as Auditor to hold
office from the
conclusion of this
meeting until the
conclusion of the next
annual general
meeting at which
accounts are laid
before the Company.
490,028,025
99.99
4,864
0.01
0
490,032,889
81.67
9. To authorise the
Directors to determine
the Auditor's
remuneration.
464,794,177
100
0
0
25,238,712
464,794,177
77.47
10. Authority to issue
and allot shares.
445,584,632
95.87
19,209,545
4.13
25,238,712
464,794,177
77.47
11. To hold shares as
Treasury Shares.
464,794,177
100
0
0
25,238,712
464,794,177
77.47
12. To execute
464,794,177
100
0
0
25,238,712
464,794,177
77.47
ancillary documents.
SPECIAL
RESOLUTIONS
13. To authorise the
Directors to dis-apply
statutory pre-emption
rights.
445,584,632
95.87
19,209,545
4.13
25,238,712
464,794,177
77.47
14. Authority for the
Company to make
market purchases of
its own shares.
464,794,177
100
0
0
25,238,712
464,794,177
77.47
Attachments
Original Link
Original Document
Permalink
Disclaimer
IDH - Integrated Diagnostics Holdings plc published this content on 30 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2023 21:07:36 UTC.
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Companyâs brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.